
|Articles|November 6, 2015
Pediatric Drug Development & Therapeutics in October TIRS
Author(s)DIA
Advertisement
The Special Section on Pediatric Therapeutics in the November, 2015 issue of
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal
2
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
3
Marty Makary Out as FDA Commissioner: Report
4
Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu
5




